UMass Cancer Center News

A total of nearly $170,000 in grants of up to $18,000 each was awarded to this year’s projects. 

The 28th annual UMass Cancer Walk raised more than $500,000 for cancer research and clinical trials at UMass Chan Medical School despite the event’s cancellation due to the nor’easter.

Talaya Reid was the first of three people living with lupus to enroll in a clinical research study at UMass Chan exploring the use of CAR T cell therapy to treat lupus nephritis.

Proceeds from the UMass Cancer Walk, returning to Polar Park on Sunday, Sept. 27, support cancer research and clinical trials at UMass Chan.

PhD candidate Emily Blackburn, MPH, received a prestigious grant from the National Cancer Institute to research proliferating cell nuclear antigen, or PCNA.

UMass Chan clinical trial studies psychedelic medication for adjustment disorder related to serious illness

Novel mRNA treatment developed at UMass Chan Medical School eliminates pancreatic cancer tumors in 50 percent of treated mice.

UMass Chan Medical School researchers have received funding from the Massachusetts Life Sciences Center to advance research using artificial intelligence to improve early identification of pregnancy-induced hypertension and to establish a colorectal cancer biobank that will accelerate biomedical discoveries.

Classrooms and labs kept busy this summer at UMass Chan, hosting high school and college students participating in outreach programs.

AMP modified vaccine adjunct activates robust T cell response.